Quantcast

Health Care Sector Update for 06/14/2019: GBT,MCRB,ARQL,NAVB


Shutterstock photo

Top Health Care Stocks

JNJ -0.29%

PFE +0.64%

ABT -0.02%

MRK +0.50%

AMGN -0.16%

Health care stocks continued to decline this afternoon, with the NYSE Health Care Index falling just over 0.2% while shares of health care companies in the S&P 500 also were down about 0.1% as a group. The Nasdaq Biotechnology index dropped more than 0.8%.

Among health care stocks moving on news:

(-) Global Blood Therapeutics ( GBT ) slipped about 6% on Friday. The early-stage biopharmaceuticals company earlier reported 24-week efficacy data showing its voxelotor drug candidate met its primary endpoint for phase III testing in patients with sickle cell disease, producing a statistically significant increase in hemoglobin levels compared with patients treated with a placebo. Voxelotor also reduced the incidence of worsening anemia and hemolysis, the company said.

In other sector news:

(+) ArQule ( ARQL ) roared to a 17-year high on Friday, climbing more than 44% to $9.08 a share, after the company released preliminary data from phase 1 testing of its ARQ 531 drug candidate, with the inhibitor of wild-type and C481S-mutant Bruton's tyrosine kinase showing "compelling clinical activity at a well-tolerated dose" in patients with relapsed or refractory hematologic malignancies who have already exhausted available therapies."

(-) Seres Therapeutics ( MCRB ) dropped almost 29% to a worst-ever $2.02 a share after the microbiome therapeutics company late Thursday priced a $60 million public offering of 26.67 million shares at $2.25 each, representing a 20.5% discount to Thursday's closing price. Seres expects to use the net proceeds, plus available cash, to advance work on its product candidates and other general corporate purposes.

(-) Navidea Biopharmaceuticals ( NAVB ) stumbled Friday, falling more than 31% to a worst-ever 68 cents a share, after the precision immuno-diagnostics company priced a $6 million public offering of 8 million shares of its common stock at 75 cents apiece, or 24.3% under Thursday's closing price.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.





This article appears in: Investing , US Markets
Referenced Symbols: GBT , ARQL , MCRB , NAVB



More from MT Newswires

Subscribe







MT Newswires
Contributor:

MT Newswires

Market News, Commodities












Research Brokers before you trade

Want to trade FX?